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Polymeric IgA is transported  from blood to bile by the rat liver (1, 2)  in a  manner 
which  may  be  analogous  to  the  transport  of  polymeric  IgA  across  the  mucosal 
epithelium.  Such transport  is thought to be mediated  by secretory component  (SC) 1 
an  epithelial  cell  glycoprotein which  acts as  a  receptor  for polymeric IgA on these 
cells (3-8). 
Fisher et  al.  (9)  recently reported  that Ig transport  by the rat  liver is selective for 
polymeric IgA and that secretory component is involved in this process because prior 
addition of SC to polymeric IgA reduced its transport.  Moreover, although IgG is not 
tran',ported,  IgG which could bind  SC  (i.e.,  anti-SC  antibodies)  was transported by 
the liver (9). 
Recently, Birheck et  al.  reported  that  transport  of polymeric IgA by the rat  liver 
proceeds through hepatic parenchymal cells  (10). Thus, if SC is involved in the IgA 
receptor which mediates transport,  it should be expressed on rat hepatocytes. 
The  experiments  presented  in  this  paper  indicate  that  SC  is  synthesized  by rat 
hepatocytes and is involved in mediating the binding of polymeric IgA to these cells. 
Materials  and Methods 
Isolation of Hepatocytes.  Rat  hepatocytes were  prepared  as  previously described  (11,  12). 
Briefly, the portal vein of 190-g Wistar rats was cannulated and the liver perfused with balanced 
Hanks' solution containing collagenase. The perfused liver was dissected from the abdomen, 
cut into pieces,  and  transferred  to the same collagenase-containing medium where the cells 
were  dissociated  by stirring  for  10  rain.  The  resulting  cell  suspension  was  filtered  through 
surgical cotton gauze and the hepatocytes were isolated by sedimentation  at  1 g as previously 
described (12). This method permitted the harvesting of a cell population that was 99% viable 
(as determined by trypan blue exclusion), consisting of >95% hepatocytes as judged by electron 
microscopy (kindly performed by Dr, M. J. Phillips, University of Toronto). 
Culture of Hepatocytes.  Rat hepatocytes were maintained in spinner flasks at a concentration 
of 1-2 ×  106 cells/ml of Waymouth's MB 752/1 medium (Grand Island Biological Co., Grand 
Island, N.  Y.),  containing  17.5% (vol/vol) heat-inactivated  horse serum,  insulin  (0.5 IU/ml, 
Connaught Medical Research Laboratory, Willowdale, Ontario), and gentamycin (50/~g/ml, 
Schering Corp., Kenilworth, N. J.). The pH and oxygen content were continuously monitored 
and  the cells  could be kept  viable  (_>65%) for up  to 2 d  as  previously described  (12).  Cell 
viability was determined by taking a sample (0.1 ml) of cell suspension and mixing with 0.05 
ml of trypan blue in 0.9% NaCI, and counting the cells in a Neubauer chamber. Four 1-mm  2 
areas were counted. 
* Supported by grants from the Medical Research Council of Canada. 
I Abbreviations used in  this paper: BSA, bovine serum albumin;  PBS, phosphate-buffered saline;  SC, 
secretory component. 
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Isolation  of  Intestinal  Epithelial  Cells,  Peripheral Blood  Lymphocytes,  Spleen  Cells,  and 
E~ythrocytes.  Suspensions of epithelial cells were obtained from the jejunum-ileum portion of 
the rat small intestine  by the method of Levine and Weintraub (13). When incubated in RPMI- 
1640 (Grand Island Biological Co.)  at a concentration of 106 cells/ml, the isolated epithelial 
cells were up to 85% viable for 3 h. 
Rat  peripheral  blood  lymphocytes were  isolated  from  heparin-treated whole  blood  by 
centrifugation on  a  Ficoll-Hypaque density gradient  (density  ---  1.077 g/ml).  Cells  were 
incubated at a concentration of 10  e lymphoeytes/ml in RPMI-1640. 
Rat spleen cells were obtained by cutting the spleen into small pieces, mincing in McCoy's 
medium (Grand Island Biological Co.),  and filtering through a steel gauze to obtain a single 
cell suspension. They were centrifuged and the cell pellet was washed twice with phosphate- 
buffered saline (PBS; 0.15 M  NaCI, 0.01 M potassium phosphate, pH 7.3). 
Rat  erythrocytes were  collected  into tubes containing heparin  (10  U/ml of blood)  and 
washed three times with PBS. 
Proteins.  Rat monoclonal proteins were obtained from the serum of rats bearing immuno- 
cytomas  (14). Rat  IgA  monoclonal protein  (IR22)  was  isolated  from  serum  by  methods 
previously described by Fisher et al. (9). 
Rat SC was isolated by affinity chromatography employing human polymeric immunoglob- 
ulins coupled to Sepharose 4B as the affinity immunosorbent, as described by Underdown and 
Socken (15). The rat SC was able to competitively inhibit the binding of human 12~I-SC to 
either human or rat polymeric IgA in vitro. 
Antisera to  rat  IgA,  IgM,  IgG,  albumin, and whole serum were  purchased  from  Miles 
Laboratories Inc., (Miles Research Products, Elkhart, Ind.) or prepared in our own laboratory 
by multiple immunizations  of rabbits with purified monoclonal proteins, as previously described 
(9). Antiserum specific  for rat SC was prepared as previously reported  (15). The anti-rat SC 
antisera gave a  pattern of identity when purified rat  SC  and secretory IgA were tested in 
adjacent wells by immunodiffusion. No reactions were observed when the anti-SC antiserum 
was tested against rat serum or rat myeloma proteins. Specific rabbit antibodies to rat SC were 
isolated and purified by affinity chromatography as previously described (9). 
Purified polymeric rat IgA and rat SC were labeled by the iodine monoehloride method as 
previously described  (5). The specific  activity of 125I-proteins was  calculated in counts per 
minute per micromole by the measurement of radioactivity in a gamma counter and absorbance 
at 278 nm. The elution volumes of ~2SI-proteins  were identical to the unlabeled proteins when 
filtered on Sepharose 6B and Sephadex G-200 (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc., Piscataway, N. J.) in PBS.  Iodinated proteins were stored at 4°C. 
Determination of Rat SC Concentration.  Rat SC was measured by a double-antibody radioim- 
munoassay technique according to Gleich et al. (16). Rabbit antiserum to rat SC (100 #1 in a 
1% solution diluted in PBS)  was added to 200 pl of inhibitor (either bovine serum albumin 
[BSA]/PBS, SC standard solutions in BSA/PBS, or samples of hepatocyte-containing  medium). 
Preliminary experiments were carried out to determine the dilution of anti-rat SC that, in the 
absence of inhibitor, would bind 60 or 70% of the radiolabeled rat SC subsequently  added. The 
125  mixture was incubated for 1 h at room temperature after which 50/d of rat  I-SC was added 
(0.1 #g containing 1.0 ×  104 cpm). 
The resulting mixture was incubated for a further hour at room temperature and then 200 
#1 of sheep antiserum to rabbit IgG was added,  which was  previously determined to be in 
antibody excess by quantitative precipitation analysis. Precipitates formed after incubation at 
4°C for  18 h, and were washed three times in cold PBS, isolated by centrifugation (1,200 g), 
and counted in a  gamma counter. In the absence of inhibitor, 68%  of the rat  x25I-SC was 
precipitated by the addition of anti-rat SC, whereas only 6% was precipitated in the presence 
of 100 #1 of normal rabbit serum. 
SC Synthesis by Hepatocytes.  The method used was  similar to that  previously reported for 
albumin (11, 12). 3-ml aliquots of a suspension of cultured hepatocytes were taken at several 
times after the initiation  of culture and ultrasonieated (model W140D, Heat Systems-Ultrason- 
ics, Inc., Plainview, N. Y.). The sample was then used as an inhibitor in the double-antibody 
assay for SC as described above. Alternatively, in some cases only the incubation supernate was 
assayed. 
Secretory component associated with the surface of various cell types was also analyzed by 1540  SECRETORY  COMPONENT  AS AN  IgA RECEPTOR 
the double-antibody radioimmunoassay. Cells (105-108 cells in  150 ~1 of medium) were added 
to 100 til of rabbit anti-rat SC and the mixture was incubated at 4°C for 1 h, after which the 
cells were removed by centrifugation. The supernate was then added to rat I~I-SC, followed by 
sheep anti-rabbit IgG as described in the standard double-antibody assay. The quantity of SC 
associated with each cell type was estimated by comparing the degree of inhibition obtained 
with each cell type to that of soluble secretory component. 
Binding of IgA to Hepatocytes.  To study the binding of rat 125I-IgA to hepatocytes, cells were 
taken from spinner flasks, centrifuged at 150 g, and washed in BSA/PBS three times. The cells 
were resuspended and  filtered through  glass wool to remove aggregates. Varying quantities 
(0.1-10/lg) of radiolabeled rat IgA were added to 3 ×  105 hepatocytes in a final vol of 200 Ill 
of 30 mg BSA/ml PBS, in the presence or absence of 1,0 mg of human IgA dimer to detect 
specific binding. (Our previous studies indicated that human IgA dimer could block the biliary 
transport of rat IgA [9].) The mixture was incubated for 30 min at 22°C. Cells were centrifuged 
(150 g) and washed three times in PBS and the quantity of radioactivity bound in the presence 
or absence of unlabeled protein was then determined. The ability of various proteins to inhibit 
the binding of rat x25I-IgA to hepatocytes was also studied. In the inhibition experiments, the 
quantity of rat a25I-IgA used was sufficient to saturate  16% or alternatively 100% of the IgA- 
binding sites. 
Immunofluorescence.  The  IgG  fraction  of sheep  antiserum  to  rabbit  IgG was  purified by 
fractionation on DEAE-cellulose using 0.05 M  Tris-HCl, 0.01  M  NaCI, pH 8.0.  The purified 
sheep IgG (anti-rabbit IgG) was conjugated with rhodamine (Lissamine rhodamine B, RB 200 
sodium salt, lot 27285-A, ICN K  & K  Laboratories, Inc., Plainview, N. Y.)  by the method of 
Nairn et  al.  (17).  The  rhodamine conjugate was gel filtered over a  Sephadex G-25 column 
equilibrated with PBS to remove free dye. An adsorption step using mouse liver powder (N. L. 
Cappel Laboratories, Inc., Cochranville, Pa.) at a final concentration of 50 mg/ml of conjugate 
(stirred for 30 min at room temperature and then centrifuged at  12,000 g for 5 min) was used 
to decrease diffuse background staining. The molar F/P ratio was 2.5. 
To demonstrate SC on the surface of hepatocytes, cells were incubated with either purified 
rabbit IgG anti-rat SC antibodies (50 ~tg/105 cells in  100/ll of 30 mg BSA/PBS) or an equal 
weight of rabbit IgG for 20 min at 22°C. The cells were washed in BSA/PBS three times and 
incubated with rhodamine-sheep anti-rabbit IgG for 20 min at 22°C. The cells were washed 
three times and placed on a microscope slide to air dry. Buffered glycerin (90% glycerin in PBS) 
was added to the slide and a cover slip placed on the slide and the cells examined with a Zeiss 
epi-fluorescent microscope (Carl Zeiss, Inc., New York). 
Results 
Synthesis  of Rat  SC  by  Hepatocytes.  Radioimmunoassay  of sonicated culture  fluid 
containing hepatocytes demonstrated  synthesis of SC  over a  48-h  period.  Synthesis 
was  calculated  by  subtracting  the  SC  contained  in  the  sonicated  samples  at  the 
initiation of culture from that present at the time points shi3wn (Fig. 1). No significant 
difference between the sonicated samples of cells plus culture fluid and culture fluid 
alone was detected, which  indicated that  the majority of SC  measured  under  these 
conditions was secreted. 
To  confirm  that the  double-antibody assay was  specifically determining SC,  the 
culture medium was gel filtered on Sephadex (]-200 in PBS and the effluent analyzed 
for SC activity. It was revealed that  the SC activity appeared in two  fractions, one 
corresponding to  free rat  SC  and  the other at  the  void volume consistent with  SC 
bound to polymeric horse immunoglobulins. 
When 0.5/~g of Actinomycin D  per milliliter of medium  (Sigma Chemical Co., St. 
Louis, Mo.) was added after cells had been incubated for 12 h, synthesis and secretion 
of SC ceased (Fig.  1). This further suggested that the presence of SC represented de 
novo synthesis and not release of SC which had been taken up by hepatocytes in vivo. SOCKEN ET AL.  1541 
A 
O9 
W 
F- 
¢9 
O  p- 
n 
W  "1" 
O 
O~ 
F- 
ry" 
Fie.  1. 
0.08 
0.07 
0.06 
0.05 
0.04 
0.03 
0.02 
0.01 
ACTINOMYCIN D ADDED 
I  I  [  I 
0  6  12  24  48 
TIME OF INCUBATION (h) 
Demonstration of the synthesis of SC by hepatoeytes over  a 48-h period. When a metabolic 
inhibitor, Actinomycin  D, was added after the cells had been incubated for 12 h, the synthesis and 
secretion of SC ceased. 
Hepatocyte-associated  SC  Determined  by  Radiolabeled  and  Rhodamine-labeled 
Antibodies.  Because  hapatocytes  synthesized  SC,  we  turned  out  attention  to  the 
possibility  that  SC  might  be  present  on  the  surface  of hepatocytes.  Preliminary 
experiments  indicated  that  a~I-anti-rat  SC  antibodies  were  capable  of binding to 
washed hepatocytes. Moreover, the binding of 125I-anti-SC  was specifically inhibited 
by unlabeled specifically purified rabbit IgG anti-rat SC antibodies but not by normal 
rabbit  IgG (Fig.  2).  Althotigh 30/~g of specifically purified rabbit  IgG anti-rat  SC 
antibodies caused 50%  inhibition, as much as  10 mg of normal rabbit IgG had little 
effect (Fig.  2). 
Immunofluorescent staining was also employed to demonstrate SC on the surface 
of hepatocytes. The results observed when live hepatocytes were stained are shown in 
Fig. 3. A variety of patterns were observed including diffuse membrane staining and 
patching and/or capping (Fig.  3). 
In different experiments,  between  25  and  50%  of cells  were stained with anti-SC 
whereas <5% of cells treated with normal rabbit IgG were positive. The results shown 
in  Fig.  3  were  obtained when cells  were stained  at  room temperature.  In separate 
experiments  in  which cells were stained  at  2°C,  no caps were observed. A  detailed 
study on  the  movement  of SC  within  the  hepatocyte membrane  will  be  reported 
elsewhere. 
Detection of  SC Molecules Associated with Hepatocytes by Radioimmunoassay.  SC molecules 1542  SECRETORY  COMPONENT  AS  AN  IgA  RECEPTOR 
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FIG.  2.  Binding of 1251-anti-rat SC antibodies to washed hepatocytes was inhibitable by unlabeled 
specifically purified rabbit IgG anti-rat SC (0), but not by as much as lO0-fold excess normal rabbit 
IgG (0), 
on the surface of hepatocytes were detected by using washed cells as inhibitors in the 
double-antibody radioimmunoassay for SC. The results are shown in Table I. Between 
1.4 and 3.4  ×  105 molecules of rat SC per hepatocyte were calculated. This number 
was similar to that  found for rat jejunum-ileum epithelial cells, which had between 
1.0 and 2.0 ×  105 molecules of SC per cell. In contrast, the number of SC molecules 
was found to be <5.0 ×  102 per cell in peripheral blood lymphocytes, unfractionated 
spleen  cells,  and  rat  erythrocytes.  Experiments  were  carried  out  to  exclude  the 
possibility that  the  calculated  number of SC  molecules per cell was  influenced  by 
secretion of SC during the  1-h incubation  period with the anti-SC antiserum.  Cells 
were incubated  in  BSA/PBS  for  1 h  and  the supernate  assayed for rat  SC.  Under 
these conditions  insufficient  SC  was secreted to interfere with  the determination  of 
membrane-bound SC. 
Role of SC in Binding of Rat 125I-IgA to Hepatocytes.  Our previous studies (9) indicated 
that  the  transport  of IgA by the  rat  liver may proceed by a  secretory component- 
mediated  mechanism  similar  to  that  proposed  for the  transport  of IgA across  the 
mucosal epithelium. Therefore, it was of interest to determine whether rat IgA could 
bind  to  isolated  rat  hepatocytes and  if such binding was mediated  by hepatocyte- 
associated SC. 
The binding of rat  125I-IgA was studied  in competitive inhibition  experiments in 
which  x25I-IgA  was  added  to  hepatocytes  in  the  presence  or  absence  of  various 
unlabeled proteins (Fig. 4). Such competitive inhibition experiments were carried out 
at two different doses of rat  125I-IgA added,  corresponding to -16  and  100%  of the 
IgA-binding sites saturated, with similar results. A representative experiment is shown 
in Fig. 4. Unlabeled rat dimeric IgA consistently inhibited the binding of rat 125I-IgA, 
whereas  while  <20%  inhibition  was  obtained  when  as  much  as  10-fold  greater 
quantities  of a  series of rat and human proteins were tested.  Inhibition by rat IgG, 
IgE,  and  albumin  were  considered  to  be  nonspecific  because  inhibition  by  these 
proteins  was  not  significantly  different  from  control  tubes  containing  BSA/PBS. 
Moreover, inhibition by these latter proteins did not take place in a  dose-dependent 
fashion  and  was  <20%  at  all  doses.  In  contrast,  inhibition  by  rat  IgA was  dose- 
dependent  (Fig. 5). Rat IgM, at a  10-fold greater concentration than rat IgA, did not 
inhibit  the binding  of rat  12sI-IgA  as well.  This was expected  because rat  IgM-SC SOCKEN  ET  AL.  1543 
FIG. 3.  Indirect immunofluorescence demonstrating the presence of SC on the plasma membrane 
of isolated  rat  hepatocytes.  Magnification:  ×  400. (a,  top)  and  (b,  bottom)  are  photographs 
representing the two main patterns of staining which were observed. 
interactions are weak (15).  In a  series of additional experiments (not shown), human 
myeloma IgA dimers were able to  competitively inhibit  the  binding of rat  125I-IgA 
whereas human secretory IgA dimer or human IgA monomer were unable to compete 
with rat  12~I-IgA for binding to rat hepatocytes. 
Thus,  the competitive-inhibition experiments  (Fig.  4)  were  consistent  with  a  hy- 1544  SECRETORY  COMPONENT  AS  AN  IgA  RECEPTOR 
TAnL~  I 
Detection of Rat SC Molecules on a Series of Different Cell Types 
* Number of SC molecules 
Cell type  per cell 
Hepatocytes  1,4 X  10  5 
2.2 X  10  s 
3.4 X  10  5 
Intestinal  epithelial  cells  (ju-  1.0 X  10  5 
jeunum-ileum)  1.3 ×  10  ~ 
2.0 x  I0  ~ 
Unfractionated spleen cells 
Rat erythrocytes 
Peripheral blood lymphocytes 
<5.0 ×  102 
<5.0 x  102 
<5.0 X  102 
*  Each value represents the results of an individual experiment. 
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FIG.  4.  Inhibition of binding of rat  125I-IgA to isolated rat hepatoeytes. The amount of lzbI-IgA 
corresponded to 100% saturation in the absence of inhibitor. (IgA)2,  unlabeled rat IgA dimer; IgM, 
IgG, and IgE were rat  proteins;  BG, correspondent  to the experimental variation  in the control 
points in which only BSA was added.  The error bars are standard deviations of the mean of six 
individual determinations. 
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FIG.  5.  Dose-dependent inhibition of rat l~I-IgA by unlabeled rat IgA. The error bars represent 
standard deviations of the means of six individual determinations. SOCKEN  ET  AL.  1545 
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Flo.  6.  Inhibition of binding of rat 'zsI-IgA to hepatocytes. (a)  Cells were treated with IgG anti- 
SC antibodies or normal IgG, before addition of 125I-IgA; 0a) l~I-IgA was incubated either with rat 
SC or BSA before incubation with hepatocytes. 
pothesis that rat 12~I-polymeric  IgA was binding to SC on hepatoeytes because SC in 
free solution does not bind IgG, IgE, monomerie IgA, or albumin (5, and Socken and 
Underdown. Unpublished results.) and the majority of secretory IgA already contains 
SC. 
To  further  investigate  the  possibility  that  hepatocyte-associated  SC  might  be 
responsible for binding of rat  12sI-IgA, experiments were carried out  in  which  the 
binding of rat l~sI-IgA to hepatoeytes was determined in the presence of purified anti- 
rat  SC antibodies or normal rabbit  IgG as a  control. The results indicate that  the 
binding of rat  l~I-IgA was markedly reduced in the presence of rabbit  anti-rat  SC 
but not the presence of an equal or (as shown)  10-fold excess of normal rabbit  IgG 
(Fig. 6 a). 
A second approach was employed in which rat lzsI-IgA was first incubated with rat 
SC  or  BSA,  after which,  the  individual  mixtures  were  separately  incubated  with 
hepatocytes. Prior incubation with rat SC reduced the ability of rat 125I-IgA to bind 
to hepatocytes, whereas BSA showed no effect (Fig. 6 b). 
When hepatocytes were treated with trypsin (0.1-0.25%, Sigma Chemical Co.) for 
30 min at 37°C and washed three times in cold 30 mg/ml BSA/PBS, rat 125I-IgA did 
not bind to these cells. If these cells were washed and incubated for 1 h  at 37°C in 
Waymouth's medium, cells were capable of binding rat 125I-IgA, suggesting that the 
IgA-receptor had been newly synthesized. 
Discussion 
The results presented in this paper indicate that in the rat, secretory component is 1546  SECRETORY COMPONENT AS AN  IgA RECEPTOR 
synthesized  by  hepatocytes.  The  method  of  isolation  and  short-term  culture  of 
hepatocytes provided easy access to a highly purified population of hepatic parenchy- 
real cells  (11-12).  The quantity of SC  synthesized by the  hepatocyte cultures was 
significant  (Fig.  1)  but  ~1,000 times less  than previously reported for albumin  and 
100 times less than transferrin (12). 
Evidence was obtained that  SC is expressed on the surface of hepatocytes and is 
also secreted by these cells in culture. It should be noted that mucosal epithelial cells 
behave in similar fashion, i.e., SC has been found on the surface of epithelial cells (6- 
8), as well as being secreted by these cells (18). The dual distribution of SC (membrane 
and secretion) is consistent with the transport function of SC as well as its appearance 
in both biliary (19)  and mucosal secretions (20).  It is not clear what  mechanism  (if 
any) is required to allow SC to act as a receptor for transport as well as to be secreted. 
In addition to demonstrating SC on the surface of hepatocytes, specific binding of 
radiolabeled rat IgA to hepatocytes was also demonstrated and the data presented are 
consistent with  SC being involved as the IgA receptor on hepatocytes. Thus,  prior 
incubation  of  polymeric  IgA  with  rat  SC  prevented  the  IgA  from  binding  to 
hepatocytes.  Moreover, treatment  of the  hepatocytes with  anti-SC  antibodies  pre- 
vented binding of polymeric rat IgA to the hepatocytes. 
Rat  IgM  did  not  competitively  inhibit  the  binding  of rat  12~I-IgA (Fig.  4)  to 
hepatocytes as well as rat IgA. This was not unexpected as we had previously observed 
that  in the rat, SC-IgM interaction was much less prominent than in man  (15,  and 
Socken and Underdown. Unpublished results.). 
Our study and that of Hopf et al. (21) clearly indicate that binding to hepatocytes 
is specific for polymeric IgA. However, not all the polymeric IgA proteins studied by 
Hopf et al. were observed to bind to heptocytes, which led these authors to conclude 
that  binding  of polymeric IgA  to  hepatocytes was  not  mediated  by SC  but  by a 
glycoprotein receptor. However, the data presented by Hopf indicated that secretory 
IgA bound SC less well (as expected because 85% of secretory IgA contains SC) and 
showed a corresponding decrease in binding to hepatocytes. 
The experiments of Fisher et al. indicate that biliary transport of polymeric IgA is 
mediated  by liver-associated  SC.  More  recently, Birbeck et  al.  demonstrated  that 
biliary transport of IgA in the rat, proceeds through hepatocyte parenchymal cells. 
The experiments reported here indicate that  SC mediates the binding of polymeric 
IgA to hepatocytes and that SC is part of the IgA receptor-complex on hepatocytes. 
It  seems  likely that  for SC  to  function as  a  receptor on  the  hepatocyte plasma 
membrane it must either be associated with an integral membrane protein or differ 
in structure from the freely water-soluble-free SC. 
The hepatocyte appears  to possess  a  number of different receptors on its plasma 
membrane which  mediate the transport  of a  number of different proteins  (22-25). 
The IgA transport system is relatively unique in that a part of the receptor complex 
is a protein which has been isolated and characterized (ile., SC). Bi!iary transport of 
polymeric IgA may proceed by a vesicular mechanism as has been proposed for other 
proteins  transported  by  hepatocytes  (26)  and  for  IgA  transported  by  intestinal 
epithelial cells (6). Because the majority of IgA transported to bile is intact polymers 
(9), a  mechanism  may exist to prevent the IgA from being degraded by lysozomal 
vesicles within  the  cell.  It  may be that  IgA-containing vesicles are protected by a 
clathrin coat  (27)  during transport  through the hepatocyte. It will be of interest to SOCKEN ET AL.  1547 
determine whether membrane-associated SC is physically related to clathrin or other 
proteins on the hepatocyte surface. 
Summary 
Secretory component (SC) was found to be synthesized by isolated rat hepatocytes. 
SC  was  detected  by  radioimmunoassay  and  cultured  hepatocytes  were  found  to 
synthesize 0.078 #g SC/106 hepatocytes in a  48-h period. SC was also present on the 
surface  of hepatocytes  as  detected  by the  specific binding  of radiolabeled  anti-SC 
antibodies  as  well  as  by  the  detection  of specific  membrane  staining  in  indirect 
immunofluorescence tests using specifically purified anti-SC antibodies.  Rat SC was 
detected  on hepatocytes and  intestinal  epithelial  cells but  not  on peripheral  blood 
lymphocytes, unfractionated  spleen cells, or erythrocytes. Specific binding of radio- 
labeled  rat  dimeric  IgA  to  rat  hepatocytes  was  also  observed  and  evidence  was 
obtained to indicate that such binding was mediated by SC. Thus, prior incubation 
of hepatocytes with anti-SC prevented binding of radiolabeled IgA. Moreover, prior 
incubation of radiolabeled IgA with rat SC prevented binding of the IgA to isolated 
hepatocytes. Cells treated with 0.25% trypsin lost their ability to bind to radiolabeled 
dimeric IgA. 
We wish to thank Mr. Joseph Ho for his excellent  assistance  in isolating rat hepatocytes, Ms. 
Sandra Kuzniak for help in isolating specific antibodies to SC, and Ms. Patricia Rapacehietta 
for typing the manuscript. We also are indebted to J. M. Schiff for valuable discussions. 
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